CA Patent

CA2693992C — Methods of improving the pharmacokinetics of doxepin

Assigned to Currax Pharmaceuticals LLC · Expires 2017-01-31 · 9y expired

What this patent protects

Methods of improving the pharmacokinetics of doxepin in a patient.

USPTO Abstract

Methods of improving the pharmacokinetics of doxepin in a patient.

Drugs covered by this patent

doxepin-hydrochloride (DOXEPIN HYDROCHLORIDE)

Patent Metadata

Patent number: CA2693992C
Jurisdiction: CA
Classification: —
Expires: 2017-01-31
Drug substance claim: No
Drug product claim: No
Assignee: Currax Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.